Video-assisted thoracoscopic lobectomy for non-small cell lung cancer: a morbidity limiting approach in a patient on chronic hemodialysis and double agent antiplatelet therapy

Gen Thorac Cardiovasc Surg. 2015 Mar;63(3):177-80. doi: 10.1007/s11748-013-0294-5. Epub 2013 Jul 25.

Abstract

Patients with end-stage renal disease on hemodialysis undergoing surgery for lung cancer represent a high-risk group because of electrolyte imbalance, anemia, hemodynamic instability, bleeding tendency, and immunocompromised state. We describe a patient on hemodialysis with three lung adenocarcinoma of the right lower lobe as an incidental finding during the clinical course of a myocardial infarction treated with drug-eluting stent implantation and double-agent antiplatelet therapy. Considering patient comorbidities, we decided to perform a right lower lobectomy and complete lymph node dissection by a minimally invasive technique. In our experience, the thoracoscopic approach allowed us to perform lobectomy with complete lymph nodes dissection without morbidity. The use of ultrasound scalpel permits a complete lymph node dissection minimizing bleeding even in a double antiplatelet therapy patient.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Carcinoma, Non-Small-Cell Lung / surgery*
  • Humans
  • Kidney Failure, Chronic / therapy
  • Lung / pathology
  • Lung / surgery
  • Lung Neoplasms / surgery*
  • Lymph Node Excision / methods
  • Male
  • Morbidity
  • Platelet Aggregation Inhibitors / therapeutic use
  • Pneumonectomy / methods*
  • Renal Dialysis
  • Thoracic Surgery, Video-Assisted / methods*
  • Thoracoscopy*
  • Tomography, X-Ray Computed

Substances

  • Platelet Aggregation Inhibitors